12:32 PM
Sep 10, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Encephalopathy

Patient sample and mouse studies suggest inhibiting the JAK/STAT1 pathway, the interaction between MCP-1 and CCR2, or phagocyte activation could help treat Rasmussen encephalitis. In postmortem brain samples from patients, levels of phosphorylated STAT1 and MCP-1 and the number of activated phagocytes were higher than in samples from patients with non-neurological diseases. In a mouse model of Rasmussen encephalitis, inhibiting...

Read the full 283 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >